Skip to main content
SpringerLink
Log in

Saponins as immunoadjuvants and immunostimulants

  • Chapter
Immunomodulatory Agents from Plants

Part of the book series: Progress in Inflammation Research ((PIR))

Abstract

Saponins are either triterpene or steroid glycosides widely distributed in the plant and animal kingdom and include a large number of biologically active compounds. Most of them have surface-active and cholesterol-binding properties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lacaille-Dubois MA, Wagner H (1996) Biological and pharmacological activities of saponins. Phytomedicine 4: 363–383

    Article  Google Scholar 

  2. Waller GR, Yamazaki K (eds) (1996) Saponins used in traditional and modern medicine ACS symposium on saponins: chemistry and biological activity (Chicago, 1995). Plenum Press, New York

    Google Scholar 

  3. Hostettmann K, Marston A (1995) Saponins. Cambridge University Press, Cambridge

    Book  Google Scholar 

  4. Cox JC, Coulter AR (1997) Adjuvants - a classification and review of their mode of action. Vaccine 15: 248–256

    Article  PubMed  CAS  Google Scholar 

  5. Gupta RK, Siber GR (1995) Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13: 1263–1276

    Article  PubMed  CAS  Google Scholar 

  6. Bomford R (1992) Adjuvants for viral vaccines. Reviews in Medical Virology 2: 169–174

    Article  CAS  Google Scholar 

  7. Zhao Z, Leong KW (1996) Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci 85:1261–1270

    Article  PubMed  CAS  Google Scholar 

  8. Kersten GFA (1990) Aspects of ISCOMs: Analytical, pharmaceutical and adjuvant properties. Thesis, National Institute for public health and environmental protection, Biltoven, The Netherlands and the department of Pharmaceutics, University of Utrecht, The Netherlands

    Google Scholar 

  9. Kensil CR (1996) Saponins as vaccine adjuvants. Critical Reviews in Therapeutic Drug Carrier-Systems 13: 1–55

    CAS  Google Scholar 

  10. Campbell JB, Peerbaye YA (1992) Saponin. Res Immunol 143: 526–530

    Article  PubMed  CAS  Google Scholar 

  11. Vogel FR, Powell MF (1995) Compendium of vaccine adjuvants and excipients. In: MF Powell, MJ Newmann (eds): Vaccine design: The subunit and adjuvant approach. Plenum Press, New York, 141–228

    Google Scholar 

  12. Higuchi R, Tokimitsu Y, Komori T (1988) An acylated triterpenoid saponin from Quillaja saponaria. Phytochemistry 27: 1165–1168

    Article  CAS  Google Scholar 

  13. Kensil CR, Patel U, Lennick CK, Marciani D (1991) Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina Cortex. J Immunol 146: 431–437

    PubMed  CAS  Google Scholar 

  14. Kensil CR, Wu JY, Soltysik S (1995) Structural and immunological characterization of the vaccine adjuvant QS 21. In: MF Powell, MJ Newmann (eds): Vaccine design: The subunit and adjuvant approach. Plenum Press, New York, 525–541

    Google Scholar 

  15. Bomford R, Stapleton M, Winsor S, Beesley JE, Jessup EA, Price KR, Fenwick GR (1992) Adjuvanticity and ISCOM formation by structurally diverse saponins. Vaccine 10: 572–578

    Article  PubMed  CAS  Google Scholar 

  16. Bomford R, Stapleton M, Winsor S, Mcknight A, Andronova T (1992) The control of antibody isotype response to recombinant human immunodeficiency virus gp 120 antigen by adjuvants. AIDS Res Human Retroviruses 8: 1765–1771

    Article  CAS  Google Scholar 

  17. Flebbe LM, Braley-Mullen H (1986) Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations. Cell Immunol 99: 128–139

    Article  PubMed  CAS  Google Scholar 

  18. Stott EJ, Chan WL, Mills KHG, Page M, Taffs F, Cranage M, Greenaway P, Kitchin P (1990) Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed-infected cell vaccine. Lancet Dec 22/29: 1538–1541

    Article  Google Scholar 

  19. Kensil CR, Newman MJ, Coughlin RT, Soltysik S, Bedore D, Recchia J, Wu JY, Marciani DJ (1993) The use of stimulon adjuvant to boost vaccine response. Vaccine Res 2: 273–281

    CAS  Google Scholar 

  20. Britt W, Fay J, Seals J, Kensil, C (1995) Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice. J Infect Dis 171: 18–25

    Article  PubMed  CAS  Google Scholar 

  21. Hancock GE, Speelman DJ, Frenchick PJ, Mineo-Kuhn MM, Baggs RB, Hahn DJ (1995) Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection. Vaccine 13: 391–400

    Article  PubMed  CAS  Google Scholar 

  22. Clark N, Kushner NN, Barrett CB, Kensil CR, Salsbury D, Cotter S (1991) Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection. J Amer Veterin Med Assoc 199: 1433–1443

    CAS  Google Scholar 

  23. Ma J, Bulger PA, vR Davis D, Perilli-Palmer B, Bedore DA, Kensil CR, Young EM, Hung CH, Seals JR, Pavia CS et al (1994) Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and Osp B of Bor-relia burgdorferi. Vaccine 12: 925–932

    Article  PubMed  CAS  Google Scholar 

  24. White AC, Cloutier P, Coughlin RT (1991) A purified saponin acts as an adjuvant for a T-independent antigen. Immunobiol of Proteins and Peptides VI, 207–210

    Article  Google Scholar 

  25. Newmann MJ, Wu JY, Coughlin RT, Murphy CL, Seals JR, Wyand, MS, Kensil CR (1992) Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in non human primates. AIDS Res Human Retroviruses 8: 1413–1418

    Google Scholar 

  26. Coughlin RT, Fish D, Mather TN, Ma J, Pavia C, Bulger P (1995) Protection of dogs from lyme disease with a vaccine containing outer surface protein (Osp)A, Osp B, and the saponin adjuvant QS-21. J Infect Dis 171: 1049–1052

    Article  PubMed  CAS  Google Scholar 

  27. Wu JY, Gardner, BH, Murphy CI, Seals JR, Kensil CR, Recchia J, Beltz GA, Newman GW, Newman MJ (1992) Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. Vaccine 148: 1519–1525

    CAS  Google Scholar 

  28. Newman MJ, Wu JY, Gardner BH, Munroe KJ, Leombruno D, Recchia J, Kensil CR, Coughlin RT (1992) Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J Immunol 148: 2357–2362

    PubMed  CAS  Google Scholar 

  29. Newman MJ, Munroe KJ, Anderson CA, Murphy CI, Panicali DL, Seals JR, Wu JY, Wiand MS, Kensil CR (1994) Induction of antigen-specific killer T lymphocyte responses using subunit SIV mac251 gag and env vaccines containing QS-21 saponin adjuvant. AIDS Res Human Retroviruses 10: 853–861

    CAS  Google Scholar 

  30. Chavali SR, Barton LD, Campbell JB (1988) Immunopotentiation by orally-administered Quillaja saponins: effects in mice vaccinated intraperitoneally against rabies. Clin Exp Immunol 74: 339–343

    PubMed  CAS  Google Scholar 

  31. Wu JY, Gardner BH, Kushner NN, Pozzi LAM, Kensil CR, Cloutier PA, Coughlin RT, Newman MJ (1994) Accessory cell requirements for saponin adjuvant-induced class I MHC antigen restricted cytotoxic T-lymphocytes. Cell Immunol 154: 393–406

    Article  PubMed  CAS  Google Scholar 

  32. Kensil CR, Soltysik S, Wheeler DA, Wu JY (1996) Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria in: GR Waller, K Yamasaki (eds): Saponins used in traditional and medicinal medicine. Plenum Press, New York, 165–172

    Google Scholar 

  33. Soltysik S, Wu JY, Recchia J, Wheeler DA, Newman MJ, Coughlin RT, Kensil CR (1995) Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 13:1403–1410

    Article  PubMed  CAS  Google Scholar 

  34. Livingston PO, Adluri S, Helling F, Yao TJ, Kensil CR, Newman MJ, Marciani D (1994) Phase 1 trial of immunological adjuvant with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine 12: 1275–1280

    Article  PubMed  CAS  Google Scholar 

  35. Helling F, Zhang S, Shang A, Adluri S, Calves M, Koganty R, Longenecker BM, Yao TJ, Oettgen HF, Livingston PO (1995) GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res 55: 2783–2788

    PubMed  CAS  Google Scholar 

  36. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garçon N, Kazych U, Marchand M et al (1997) A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 336: 86–91

    Article  PubMed  CAS  Google Scholar 

  37. Morein B, Sundquist B, Höglund S, Dalsgaard K, Osterhaus A (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308: 457–462

    Article  PubMed  CAS  Google Scholar 

  38. Barr IG, Mitchell GF (1996) ISCOMs (immunostimulating complexes): The first decade. Immunol Cell Biol 74: 8–25

    Article  PubMed  CAS  Google Scholar 

  39. Morein B, Lövgren K, Höglund S, Sundquist B (1987) The ISCOM: an immunostimulating complex. Immmunol Today 8: 333–338

    Article  CAS  Google Scholar 

  40. Claassen I, Osterhaus A (1992) The iscom structure as an immune-enhancing moiety: experience with viral systems. Res Immunol 143: 531–541

    Article  PubMed  CAS  Google Scholar 

  41. Rimmelzwaan GF, Osterhaus AD (1995) A novel generation of viral vaccines based on the ISCOM matrix. In: MF Powell, MJ Newmann (eds): Vaccine design: The subunit and adjuvant approach. Plenum Press, New York, 543–558

    Google Scholar 

  42. Villacres-Eriksson M (1993) Induction of immune response by ISCOMs. Doctor Thesis, University of Uppsala

    Google Scholar 

  43. Takahashi H, Takeshita T, Morein B, Putney S, Germain RN, Berzofsky JA (1990) Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344: 873–875

    Article  PubMed  CAS  Google Scholar 

  44. Höglund S, Dalsgaard K, Lövgren K, Sundquist B, Osterhaus A, Morein B (1989) Iscoms and imunostimulation with viral antigens. In: JR Harris (ed): Subcellular biochemistry, Vol 15. Plenum Publishing Corporation, New York, 39–68

    Google Scholar 

  45. Lövgren Bengtsson K, Sjölander A (1996) Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant. Vaccine 14: 753–760

    Article  Google Scholar 

  46. Behboudi S, Morein B, Villacres-Eriksson M (1996) In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids. Clin Exp Immunol 105: 26–30

    Article  PubMed  CAS  Google Scholar 

  47. Rönnberg B, Fedaku M, Morein B (1995) Adjuvant activity of non toxic Quillaja saponaria Molina components for use in ISCOM matrix. Vaccine 13: 1375–1382

    Article  PubMed  Google Scholar 

  48. Rimmelzwaan GF, Baars M, van Beek R, van Amerongen G, Lövgren-Bengtsson, K, Claas EC, Osterhaus AD (1997) Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J Gen Virol 78: 757–765

    PubMed  CAS  Google Scholar 

  49. Wagner H, Proksch A (1985) Immunostimulatory drugs of fungi and higher plants. In: H Wagner, H Hikino, NR Farnsworth (eds): Economic and medicinal plant research. Academic Press, London, 1: 113–151

    Google Scholar 

  50. Wagner H, Jurcic K (1991) in: Hostettmann K (eds): Methods in plant biochemistry. Academic Press, London, 195–217

    Google Scholar 

  51. Chavali SR, Francis T, Campbell BJ (1987) An in vitro study of immunomodulatory effects of some saponins. Int J Immunopharmacol 9: 675–683

    Article  PubMed  CAS  Google Scholar 

  52. Dubois MA, Benze S, Wagner H (1990) New biologically active triterpene-saponins from Randia dumetorum. Planta Med 56: 451–455

    CAS  Google Scholar 

  53. Wagner H, Ludwig C, Grotjahn L, Khan MSY (1987) Biologically active saponins from Dodonea viscosa. Phytochemistry 26: 697–701

    Article  CAS  Google Scholar 

  54. Lacaille-Dubois MA, Hanquet B, Rustaiyan A, Wagner H (1993) Squarroside A, a biologically active triterpene saponin from Acanthophyllum squarrosum. Phytochemistry 34: 489–495

    Article  PubMed  CAS  Google Scholar 

  55. Jiang Y, Weniger B, Haag-Berrurier M, Anton R, Beck JP, Italiano L (1992) Effects of saponins from Mimosa tenuiflora on lymphoma cells and lymphocytes. Phytotherapy Res. 6: 310–313

    Article  CAS  Google Scholar 

  56. Wu RT, Chiang HC, Fu WC, Chien KY, Chung YM, Horng LY (1990) Formosanin-C an immunomodulator with antitumor activity. Int Immunopharmacol 12, 777–786

    Article  CAS  Google Scholar 

  57. Calis I, Yürüker A, Tasdemir D, Wright AD, Sticher O, De Luo Y, Pezzuto JM (1997) Cycloartane triterpene glycosides from the roots of Astragalus melanophrurius. Planta Med 63: 183–186

    Article  PubMed  CAS  Google Scholar 

  58. Ushio Y, Abe H (1991) The effects of saikosaponin on macrophage functions and lymphocyte proliferation. Planta Med 57: 511–514

    Article  PubMed  CAS  Google Scholar 

  59. Keranova B, Neychev H, Hadjivanova C, Petkov VD (1990) Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Japan J Pharmacol 54: 447–454

    Article  Google Scholar 

  60. Guinea MC, Parellada J, Lacaille-Dubois MA, Wagner H (1994) Biologically active triterpene saponins from Bupleurum fruticosum. Planta Med 60: 163–167

    Article  PubMed  CAS  Google Scholar 

  61. Kumazawa Y, Takimoto H, Nishimura C, Kawakita T, Nomoto K (1989) Activation of murine peritoneal macrophages by saikosaponin A, saikosaponin D and saikogenin D. Int J Pharmacol 11: 21–28

    CAS  Google Scholar 

  62. Lacaille-Dubois MA, Hanquet B, Cui ZH, Lou ZC, Wagner H (1997) Jenisseensosides C and D, biologically active acylated triterpene saponins from Silene jenisseensis. Phytochemistry 45: 985–990

    Article  PubMed  CAS  Google Scholar 

  63. Lacaille-Dubois MA, Hanquet B, Cui ZH, Wagner H (1997) Structure and bioactivity of a new saponin from Silene fortunei. Annual meeting of the Society for Medicinal Plant Research, Regensburg, Germany, September, 7–11, 1997, Abstract book G 18

    Google Scholar 

  64. Abe N, Ebina T, Ishida N (1982) Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Immunol 26: 535–539

    PubMed  CAS  Google Scholar 

  65. Xu JP, Xu RS, Li XY (1992) Four new cycloartane saponins from Curculigo orchioides. Planta Med 58: 208–210

    Article  PubMed  CAS  Google Scholar 

  66. Ushio Y, Abe H (1991) Effects of saikosaponin-D on the functions and morphology of macrophages. Int J Immunopharmac 13: 493–499

    Article  CAS  Google Scholar 

  67. Ushio Y, Oda Y, Abe H (1991) Effect of saikosaponin on the immune responses in mice. Int Immunopharmac 13: 501–508

    Article  CAS  Google Scholar 

  68. Yen MH, Lin CC, Yen CM (1995) The immunomodulatory effect of saikosaponin derivatives and the root extract of Bupleurum kaio in mice. Phytotherapy Res 9: 351–358

    Article  CAS  Google Scholar 

  69. Plohmann B, Bader G, Hiller K, Franz G (1997) Immunomodulatory and antitumoral effects of triterpenoid saponins. Pharmazie 52: 1–10

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Pharmacognosie, Faculté de Pharmacie, Université de Bourgogne, 7, Bd Jeanne d’Arc, F-21033, Dijon Cedex, France

    Marie-Aleth Lacaille-Dubois

Authors
  1. Marie-Aleth Lacaille-Dubois
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für pharmazeutische Biologie, Ludwig-Maximilians-Universität München, Karlstrasse 29, D-80333, München, Germany

    H. Wagner

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this chapter

Cite this chapter

Lacaille-Dubois, MA. (1999). Saponins as immunoadjuvants and immunostimulants. In: Wagner, H. (eds) Immunomodulatory Agents from Plants. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8763-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8763-2_10

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9763-1

  • Online ISBN: 978-3-0348-8763-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation